Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Development of Method of Fructose Identification in Urine to Detect the Viral Infection

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01638312
First received: January 20, 2012
Last updated: September 3, 2015
Last verified: September 2012

January 20, 2012
September 3, 2015
June 2011
May 2013   (final data collection date for primary outcome measure)
Fructose Identification in Urine to Detect the Viral Infection : Number of Participants With Positive and Negative Waveform [ Time Frame: Participants provided urine samples once ] [ Designated as safety issue: Yes ]

This detection technique, after a viral infection caused by the use of cell pathological changes and urine metabolic waste - fructose concentration, derivatives.Health News voltage changes to detect viral pathogens of activity and virulence. Because viral infection caused by the voltage change has its typical, So you can use voltage measurements to calibrate the presence and activity of a viral infection.

1.How to interpretation the data The gap between values on X-axis is σ, and 50 is a reference to the center position. For example, the sample maybe contain with HIV virus if σ≧10 units.

σ≧10 abnormal positive (+) σ<10 normal negative (-)

Not Provided
Complete list of historical versions of study NCT01638312 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Development of Method of Fructose Identification in Urine to Detect the Viral Infection
The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage
The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 20 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.
The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage.
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   None Retained
Description:
urine
Non-Probability Sample
the person who has HIV infection
Human Immunodeficiency Virus
Not Provided
HIV infection patient and health people
The study does not have intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
May 2013
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV infection

Exclusion Criteria:

  • who are in highly active antiretroviral therapy(HARRT) therapy
Both
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT01638312
KMUH-IRB-20110188
Yes
Not Provided
Not Provided
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Not Provided
Principal Investigator: JihJin Tsai, MD The Medicines Company
Kaohsiung Medical University Chung-Ho Memorial Hospital
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP